We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Since 2008, there has been no “consistent increase” in ...

SAN DIEGO — Disease-modifying antirheumatic drugs (DMARDs) and biologics were linked to as much as a 74.5% reduction in the risk for alopecia areata (AA) in patients with psoriasis, a new ...

Please provide your email address to receive an email when new articles are posted on . Sustained DMARD-free remission “does not seem attainable” for patients with RA requiring biological DMARDs, but ...

Patients with psoriatic arthritis who received bDMARDs vs cDMARDs had a lower risk for major adverse cardiovascular events, all-cause mortality, and cardiovascular mortality. Biologic ...

CHICAGO -- The current mantra of hitting rheumatoid arthritis (RA) hard and early should not equate to starting patients on biologic therapies right out of the gate, a prominent RA specialist said ...

Dr. Singh is a Professor in the Division of Rheumatology and Clinical Immunology. The primary goal of Dr. Singh’s research is to improve the outcomes of patients with arthritis and rheumatic ...